Abstract:Abstract Objective Previous studies have acknowledged the presence of eosinophilic cytoplasm in clear cell renal cell carcinoma, yet the precise quantification method and potential molecular attributes in clear cell renal cell carcinoma remain elusive. This study endeavours to precisely quantify the eosinophilic attribute and probe into the molecular mechanisms governing its presence in clear cell renal cell carcinoma. Methods Data from cohorts of clear cell renal cell carcinoma patients who underwent nephrectomy, comprising The Cancer Genome Atlas cohort (n = 475) and Sun Yat-sen University Cancer Center cohort (n = 480), were aggregated to assess the eosinophilic attribute. Additionally, Omics data from Clinical Proteomic Tumor Analysis Consortium (CPTAC) (n = 58) were leveraged to explore the potential molecular features associated with eosinophilic clear cell renal cell carcinoma. Employing receiver operating characteristic curve analysis, the proportion of tumour cells with eosinophilic cytoplasm was determined, leading to the classification of each cohort into distinct groups: a clear group (<5%) and an eosinophilic group (≥5%). Results In both cohorts, the eosinophilic feature consistently correlated with higher International Society of Urological Pathology (ISUP) grade, elevated tumor stage, and the presence of necrosis. Furthermore, the Kaplan–Meier method demonstrated that patients in the eosinophilic group exhibited shorter overall survival or disease-free survival compared with those in the clear group, a pattern reaffirmed in various stratified survival analyses. Intriguingly, within The Cancer Genome Atlas cohort, the pathological characterization of cell cytoplasm (eosinophilic vs. clear) emerged as an independent risk factor for overall survival (hazard ratio = 2.507 [95% confidence interval: 1.328–4.733], P = 0.005) or disease-free survival (hazard ratio = 1.730 [95% confidence interval: 1.062–2.818], P = 0.028) via Cox regression analysis. Moreover, multi-Omics data unveiled frequent BAP1 mutations and down-regulation of Erythroblast Transformation-Specific-Related Gene associated with the eosinophilic feature in clear cell renal cell carcinoma. Additionally, patients with low expression of Erythroblast Transformation-Specific-Related Gene showed worse overall survival (P < 0.001). Conclusions The quantification of the eosinophilic feature serves as a robust predictor of clinical prognosis in clear cell renal cell carcinoma. Furthermore, the manifestation of this feature may be linked to BAP1 mutations and the down-regulation of Erythroblast Transformation-Specific-Related Gene in clear cell renal cell carcinoma. Significantly, the expression levels of Erythroblast Transformation-Specific-Related Gene manifest as an exemplary prognostic marker, providing exceptional predictive accuracy for the clinical prognosis in clear cell renal cell carcinoma.

Research of APEH Gene Expression in Clear-Cell Renal Cell Carcinoma

Expression of EphA1 protein in clear cell renal cell carcinomas and its clinical significance

Study on Gene Expression Profiling of Renal Cell Carcinoma

Quantification of eosinophilic area and its potential molecular feature in clear cell renal cell carcinoma

Differential expression and clinical significance of serum protein among patients with clear-cell renal cell carcinoma

The Expression and Evaluation of Androgen Receptor in Human Renal Cell Carcinoma

Comprehensive Exploration of the Expression and Prognostic Value of AQPs in Clear Cell Renal Cell Carcinoma

Immunophenotyping analysis of renal cell carcinoma identified APOC1 as an immune-related biomarker and therapeutic target

Expression of the EphA1 Protein is Associated with Fuhrman Nuclear Grade in Clear Cell Renal Cell Carcinomas.

The expression and clinical significance of ALDH2 in clear renal cell carcinoma

Abnormal expression and the significant prognostic value of aquaporins in clear cell renal cell carcinoma

[Preliminary Analysis of Differentially Expressed Proteins of Clear-Cell Renal Cell Carcinoma by Comparative Proteomic Technologies].

Evaluation Of Argonaute Protein As A Predictive Marker For Human Clear Cell Renal Cell Carcinoma

Comprehensive Bioinformatics Analyses of APOBECs Family and Identification of APOBEC3D As the Unfavorable Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

Expression of HDAC7 in renal cell carcinoma and its clinical significance

Expression and clinical significance of miR-15a-5p in renal cell carcinoma

Expression of tumor-related gene rassf1a in renal cell carcinoma and its adjacent tissue

High Expression of FER Tyrosine Kinase Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma

Expression and clinical significance of CDC25C in clear cell renal cell carcinoma

CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma

Protein Phosphatase-2 A is Down-Regulated in Patients Within Clear Cell Renal Cell Carcinoma